Division of Oncological and Robotic General Surgery, Careggi University Hospital, Florence, Italy.
Division of General and Minimally Invasive Surgery, Misericordia Hospital, Grosseto, Italy.
Surg Endosc. 2017 Nov;31(11):4346-4356. doi: 10.1007/s00464-017-5507-z. Epub 2017 Apr 4.
Postoperative pancreas-related complications are quite uncommon but potentially life-threatening occurrences that may occasionally complicate the postoperative course of gastrectomy. A number of reports have described such conditions after both standard open and minimally invasive surgery. Our study has the purpose to systematically determine the pooled incidence of pancreatic events following radical gastrectomy. We also aimed to elucidate whether any difference in incidence exists between patients operated via conventional open or minimally invasive surgery.
PubMed, EMBASE, and the Cochrane Library were systematically searched for randomized or well-matched studies comparing conventional with minimally invasive oncological gastrectomy and reporting pancreas-related postoperative complications. We evaluated possible differences in outcomes between open and minimally invasive surgery. A meta-analysis of relevant comparisons was performed using RevMan 5.3.
A total of 20 studies, whereby 6 randomized and 14 non-randomized comparative studies including a total of 7336 patients, were considered eligible for data extraction. Globally, more than 1% of patients experienced some pancreatic occurrences during the postoperative course. The use of minimally invasive surgery showed a trend toward increased overall pancreatic morbidity (OR 1.39), pancreatitis (OR 2.69), and pancreatic fistula (OR 1.13).
Although minimally invasive radical gastrectomy is currently established as a valid alternative to open surgery for the treatment of gastric cancer, a higher risk of pancreas-related morbidity should be taken into account.
术后胰腺相关并发症较为罕见,但可能危及生命,偶尔会使胃癌术后的病程复杂化。许多报告都描述了标准开腹手术和微创手术后出现的这些情况。我们的研究旨在系统地确定根治性胃切除术后胰腺事件的合并发生率。我们还旨在阐明经传统开腹手术或微创手术治疗的患者之间在发病率上是否存在任何差异。
系统地检索了 PubMed、EMBASE 和 Cochrane 图书馆,以查找比较传统开腹与微创肿瘤胃切除术并报告胰腺相关术后并发症的随机或匹配良好的研究。我们评估了开腹手术和微创手术之间结果的可能差异。使用 RevMan 5.3 对相关比较进行了荟萃分析。
共纳入 20 项研究,其中 6 项随机对照研究和 14 项非随机对照研究共纳入 7336 例患者,被认为适合提取数据。总体而言,超过 1%的患者在术后过程中出现了一些胰腺并发症。微创手术的应用显示出总体胰腺发病率(OR 1.39)、胰腺炎(OR 2.69)和胰腺瘘(OR 1.13)增加的趋势。
虽然微创根治性胃切除术目前已被确立为治疗胃癌的开腹手术的有效替代方法,但应考虑与胰腺相关的发病率增加的风险。